MedTrace Logo

The Effectiveness of High Flow Nasal Cannula Versus Noninvasive Ventilation and Conventional Oxygen Therapy

NCT06593509 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-09-19

No results posted yet for this study

Summary

A prospective, randomized controlled study enrolling sixty patients who fulfilled weaning criteria after requiring invasive MV. After extubation, patients were randomized into three groups (20 patients per group) :NIV group , HFNC group, and COT group. Primary outcomes included reintubation rates at certain time points and after 48 hours post-extubation while secondary outcomes included time to reintubation , ICU length of stay, ICU mortality. Objective: To compare the rate of reintubation within 48 hours after extubation among patients receiving NIV, HFNC and COT as post-extubation respiratory support.

Conditions

  • Post Extubation Respiratory Failure

Interventions

DEVICE

Maquet,Servo I.

Model number: 06487800, Serial Number: 19761, SKU#: Inv-00344191, Made in Sweden

DEVICE

Vapotherm

INC ,100 domain drive Exeter, NH 03833, Made in U.S.A

DEVICE

venturi mask

Intersurgical Ltd, Crane House, Molly Millars Lane, Wokingham, Berkshire, RG41 2RZ, UK.,REF. 1107085, LOT,31757961

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Emad Eldine A korraa, MD · chest department ,ain shams university,cairo,egypt

  • Rehab M Mohammad, MD · chest department ,ain shams university,cairo,egypt

  • amira AA elghonemy, M.B.B.Ch · chest department ,ain shams university,cairo,egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-20
Primary Completion
2024-03-20
Completion
2024-03-20
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06593509 on ClinicalTrials.gov